sponsored links

Baxter drug fails to slow Alzheimer’s in big study

Sponsored Links

DEERFIELD, Ill. (AP) ? Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer’s disease.

View full post on Health News Headlines – Yahoo! News


Sponsored Links
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

AddThis Social Bookmark Button

Leave a Reply

You must be logged in to post a comment.